Blood test could revolutionize mental health diagnosis
NCT ID NCT06856161
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a new blood test can help tell the difference between depression and schizophrenia, and whether it can show if a treatment is working. Researchers will take blood samples and do mental health check-ins with 500 adults over several visits. The goal is to find a biological marker that makes mental health diagnosis more objective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this blood test could help doctors diagnose depression and schizophrenia more accurately and see if a treatment is working.
- What could go wrong
- This is an early observational study, not a treatment trial. The biomarker may not prove reliable enough for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL CONSUMPTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Columbian Hospital
RECRUITINGNew Westminster, British Columbia, V3L 3M2, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who returns to work after stress treatment?
- Hope in action: peer support may curb suicide risk in youth facing psychosis
- Can a brain zapping headset curb relapse in addiction?
- Can a smartphone app tame Alcohol-Related liver disease?
- Can coaching clinics curb HIV? a new strategy puts it to the test
- Can a Parent-Targeted program ease Kids' behavior problems when depression is in the picture?